Walgreens Boots Alliance, Inc. (NASDAQ: WBA) Q4 2022 earnings call dated Oct. 13, 2022 Corporate Participants: Tiffany Kanaga -- Vice President, Global Investor Relations
Walgreens Boots Alliance, Inc. (WBA) Q4 2022 Earnings Call Transcript
Categories
Health Care
Johnson & Johnson (JNJ) offers long-term stability. Is the stock a buy?
Johnson & Johnson (NYSE: JNJ) has stayed largely unaffected by the COVID crisis and macroeconomic headwinds so far, which allowed the healthcare
Why AngioDynamics (ANGO) deserves a place on investors’ watchlist
The market reopening has created a conducive atmosphere to carry out elective medical procedures which were deferred on a large scale during
ANGO Earnings: AngioDynamics Q1 loss widens. Revenue up 6%
AngioDynamics Inc. (NASDAQ: ANGO) on Friday reported a wider loss for the first quarter of 2023, despite a modest increase in revenues.
Accolade, Inc. (ACCD) Q2 2023 Earnings Call Transcript
Accolade, Inc. (NASDAQ: ACCD) Q2 2023 earnings call dated Oct. 06, 2022 Corporate Participants: Todd Friedman -- Senior Vice President of Investor Relations Rajeev
Angiodynamics Inc (ANGO) Q1 2023 Earnings Call Transcript
Angiodynamics Inc (NASDAQ: ANGO) Q1 2023 earnings call dated Oct. 06, 2022 Corporate Participants: Jim Clemmer -- President and Chief Executive Officer Stephen A.
Prime Medicine is the next big biotech to pursue IPO. Here’s all you need to know
After a soft start to the year, the IPO market has witnessed muted activity so far though a few big companies entered
FactSet Research Systems Inc. (FDS) Q4 2022 Earnings Call Transcript
FactSet Research Systems Inc. (NYSE: FDS) Q4 2022 earnings call dated Sep. 22, 2022 Corporate Participants: Kendra Brown -- Head of Investor Relations Philip
Trxade Health Inc. (NASDAQ: MEDS) Q3 2022 Research Summary
Trxade Health Inc. (NASDAQ: MEDS) is an integrated drug delivery platform that offers a digitalized retail pharmacy experience to independent pharmacies, allowing
Patterson Companies, Inc. (PDCO) Q1 2023 Earnings Call Transcript
Patterson Companies, Inc. (NASDAQ: PDCO) Q1 2023 earnings call dated Sep. 01, 2022 Corporate Participants: John Wright -- Vice President of Investor Relations Mark
IPO Alert: Third Harmonic files to go public. Here’s what you need to know
IPO activity has started gaining steam after falling significantly in the first half, in line with the global trend, but it is
Medtronic PLC (MDT) Q1 2023 Earnings Call Transcript
Medtronic PLC (NYSE: MDT) Q1 2023 earnings call dated Aug. 23, 2022 Corporate Participants: Ryan Weispfenning -- Vice President and Head of Investor Relations
Jaguar Health, Inc. (JAGX) Q2 2022 Earnings Call Transcript
Jaguar Health, Inc. (NASDAQ: JAGX) Q2 2022 earnings call dated Aug. 22, 2022 Corporate Participants: Lisa Conte -- Founder & Chief Executive Officer Carol
Bio Path Holdings Inc. (BPTH) Q2 2022 Earnings Call Transcript
Bio Path Holdings Inc. (NASDAQ: BPTH) Q2 2022 earnings call dated Aug. 16, 2022 Corporate Participants: WIll O'Connor -- Managing Director Peter Nielsen -- President and
Agilent Technologies Inc. (A) Q3 2022 Earnings Call Transcript
Agilent Technologies Inc. (NYSE: A) Q3 2022 earnings call dated Aug. 16, 2022 Corporate Participants: Parmeet Ahuja -- Vice President of Investor
Pfizer (PFE): A look at the headwinds and tailwinds this pharma giant faces in the near term
Shares of Pfizer Inc. (NYSE: PFE) were down on Monday. The stock has dropped 15% year-to-date and there is a mixed sentiment
Cipher Pharmaceuticals Inc. (CPH) Q2 2022 Earnings Call Transcript
Cipher Pharmaceuticals Inc. ( TSE: CPH) Q2 2022 earnings call dated Aug. 12, 2022 Corporate Participants: Craig Mull -- Interim Chief Executive Officer Scott
Cipher Pharmaceuticals Inc. (CPH) Q2 2022 Earnings Call Transcript
Cipher Pharmaceuticals Inc. (TSE: CPH) Q2 2022 earnings call dated Aug. 12, 2022 Corporate Participants: Craig Mull -- Interim Chief Executive Officer Scott Langille -- Chief
Cardinal Health Inc. (CAH) Q4 2022 Earnings Call Transcript
Cardinal Health Inc. (NYSE: CAH) Q4 2022 earnings call dated Aug. 11, 2022 Corporate Participants: Kevin Moran -- Vice President of Investor Relations Mike
Illumina, Inc. (ILMN) Q2 2022 Earnings Call Transcript
Illumina, Inc. (NASDAQ: ILMN) Q2 2022 earnings call dated Aug. 11, 2022 Corporate Participants: Salli Schwartz -- Vice President of Investor Relations Francis deSouza -- Chief
Veru Inc. (VERU) Q3 2022 Earnings Call Transcript
Veru Inc. (NASDAQ: VERU) Q3 2022 earnings call dated Aug. 11, 2022 Corporate Participants: Samuel Fisch -- Executive Director, Investor Relations & Corporate Communications